FDA Drug recall D-1409-2014
Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc., NDC 0008-121…
- FDA Drug
- Class II
- terminated
- Published 2014-07-02
On 2014-07-02 the FDA classified a Class II recall of Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc., NDC 0008-121… by Pfizer Us Pharmaceutical Group, citing presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 5….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1409-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-04-16 |
| Published | 2014-07-02 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Pfizer Us Pharmaceutical Group |
| Distribution | US |
Product
Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc., NDC 0008-1211-30
Reason
Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.
Identifiers
| ndc | 0008-1211-50 |
|---|---|
| ndc | 0008-1211-01 |
| ndc | 0008-1211-14 |
| ndc | 0008-1211-30 |
| ndc | 0008-1222-01 |
| ndc | 0008-1222-14 |
| ndc | 0008-1222-30 |
| ndc | 0008-1222-50 |
| ndc | 0008-1210-30 |
| code_info | H74477, H74478, Exp. 03/16, H74479, H79766 Exp. 05/16 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1409-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.